| MeSH term | MeSH ID | Detail |
|---|---|---|
| Otitis Media | D010033 | 12 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Langley JM et al. | Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. | 2004 | Pediatrics | pmid:15231980 |
| Pari L and Murugan P | Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. | 2004 | Pharmacol. Res. | pmid:14998559 |
| Park SJ and Kim SH | Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. | 2004 | J Colloid Interface Sci | pmid:14972610 |
| Pari L and Uma A | Protective effect of Sesbania grandiflora against erythromycin estolate-induced hepatotoxicity. | 2003 Sep-Oct | Therapie | pmid:14682193 |
| de Longueville F et al. | Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. | 2003 | Toxicol. Sci. | pmid:12883083 |
| Bellomo-Brandão MA et al. | Use of erythromycin for the treatment of severe chronic constipation in children. | 2003 | Braz. J. Med. Biol. Res. | pmid:14502372 |
| Lavoie JP et al. | Equine proliferative enteropathy: a cause of weight loss, colic, diarrhoea and hypoproteinaemia in foals on three breeding farms in Canada. | 2000 | Equine Vet. J. | pmid:11037264 |
| Lai CC et al. | Analysis of a commercial preparation of erythromycin estolates by tandem mass spectrometry and high performance liquid chromatography/electrospray ionization tandem mass spectrometry using an ion trap mass spectrometer. | 2000 | Rapid Commun. Mass Spectrom. | pmid:10717658 |
| Halperin SA et al. | A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. | 1999 | Pediatrics | pmid:10506267 |
| Scholz H and Noack R | Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9764549 |